November 23, 2021 by Chain Drug Review
CVS Health, installation of time delay safe technology in all 851 CVS Pharmacy locations, Tom Moriarty
Featured Articles, Leading Headlines, Pharmacy
WOONSOCKET, R.I. — As part of an ongoing commitment to helping build healthier and safer communities, CVS Health announced Tuesday the completed installation of time delay safe technology in all 851 CVS Pharmacy locations, including those in Target stores, across Texas. The company implemented the new safes initially in September at all 223 CVS Pharmacy
December 10, 2020 by Chain Drug Review
CVS Health, CVS Pharmacy, Tom Moriarty
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — As part of an ongoing commitment to helping build healthier and safer communities, CVS Health completed the installation of time delay safe technology in all of its 79 Oklahoma CVS Pharmacy locations, including those in Target stores. The safes are anticipated to help prevent pharmacy robberies and the potential for associated diversion
March 8, 2019 by Chain Drug Review
and general counsel for CVS Health, chief policy and external affairs officer, CQ Roll Call titled “Empowering Patients as Partners in Health Care”, CVS Health, PBMs, Tom Moriarty
Leading Headlines, Pharmacy
WASHINGTON — In the midst of a very important discussion around prescription drug pricing in Washington, D.C., CVS Health sponsored an event earlier this week with CQ Roll Call titled “Empowering Patients as Partners in Health Care” to focus on the issue and the consumer experience in health care. At the event, policymakers and
March 19, 2018 by Brian Bossetta and Chain Drug Review
CVS Health, drug cost transparency, high cost of prescription drugs, Tom Moriarty
2018, Issue 03-19-2018, Issues, News
WOONSOCKET, R.I. — CVS Health chief policy and external affairs officer Tom Moriarty spoke to attendees at the AHIP (America’s Health Insurance Plans) National Policy Conference in Washington, D.C., earlier this month about ways the company is addressing the high cost of prescription drugs for payers and consumers. Moriarty highlighted a variety of approaches, including
April 22, 2017 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, CVS Health, Jeffrey Woldt, Larry Merlo, Medicaid reimbursements, National Association of Chain Drug Stores, National Community Pharmacists Association, Tom Moriarty
2017, Issue 04-24-2017, Issues, Opinion
CVS Health earlier this month named Tom Moriarty to the new position of chief policy and external affairs officer. As explained by president and chief executive officer Larry Merlo, the rationale behind the creation of the role is to “deliver an integrated approach to policy development and external engagement so the company can contribute to